Table 2.
Theoretical MW | Precursor ion (MH33+) | Peptide | Sequence | Deamidation | Modified Q |
2296.192 | 767.06 | 1–20 | VRVPVPQLQPQNPSQQQPQE | 2 | 7/11 |
2328.146 | 777.71 | 10–29 | PQNPSQQQPQEQVPLVQQQQ | 2 | 21/16 |
2335.196 | 780.40 | 20–39 | EQVPLVQQQQFLGQQQPFPP | 3 | 21/27 or 28/34 |
2368.164 | 791.09 | 30–49 | FLGQQQPFPPQQPYPQPQPF | 2 | 34/40 |
2411.191 | 805.06 | 40–59 | QQPYPQPQPFPSQQPYLQLQ | 1 | 52 |
2355.19 | 786.63 | 50–69 | PSQQPYLQLQPFPQPQLPYS | 2 | 52/65 |
2376.201 | 793.75 | 60–79 | PFPQPQLPYSQPQPFRPQQP | 1 | 65 |
2438.171 | 814.40 | 70–89 | QPQPFRPQQPYPQPQPQYSQ | 2 | 77/86 |
2397.135 | 800.70 | 80–99 | YPQPQPQYSQPQQPISQQQQ | 2 | 86/91 |
2461.169 | 90–109 | PQQPISQQQQQQQQQQQQQQ | 0 | ||
2549.233 | 100–119 | QQQQQQQQQQQQQQQQILQQ | * | ||
2436.260 | 110–129 | QQQQQQILQQILQQQLIPCM | * | ||
2303.210 | 769.45 | 120–139 | ILQQQLIPCMDVVLQQHNIA | 1 | 123 or 124 |
2256.172 | 130–149 | DVVLQQHNIAHGRSQVLQQS | 0 | ||
2324.125 | 766.04 | 141–160 | GRSQVLQQSTYQLLQELCCQ | 1 | 148 |
2459.161 | 150–169 | TYQLLQELCCQHLWQIPEQS | 0 | ||
2408.217 | 160–179 | QHLWQIPEQSQCQAIHKVVH | 0 | ||
2349.281 | 784.01 | 170–189 | QCQAIHKVVHAIILHQQQKQ | 0 | |
2322.208 | 775.40 | 180–199 | AIILHQQQKQQQQPSSQVSF | 1 | 191 |
2287.123 | 764.04 | 190–209 | QQQPSSQVSFQQPLQQYPLG | 2 | 200/205 |
2300.132 | 768.04 | 200–219 | QQPLQQYPLGQGSFRPSQQN | 1 | 205 |
2168.031 | 724.01 | 210–229 | QGSFRPSQQNPQAQGSVQPQ | 1 | 223 |
2293.140 | 766.05 | 220–239 | PQAQGSVQPQQLPQFEEIRN | 2 | 223/230 |
2314.181 | 230–249 | QLPQFEEIRNLALQTLPAMC | 0 | ||
2223.114 | 240–259 | LALQTLPAMCNVYIPPYCTI | 0 | ||
2116.034 | 250–268 | NVYIPPYCTITPFGIFGTN | 0 |
* Peptides not analyzed due to solubility problem are indicated with an asterisk. It was not possible to define which of the underlined Q residues is deamidated in peptides 20–39 and 120–139.